Steven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USADr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of Urology, Journal of Urology, Wiley's BJUI and Urology Times. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.Kevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USADr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the Journal of Urology, Journal of the American Medical Association (JAMA), New England Journal of Medicine, International Journal of Impotence Research, and Urology. He is an editorial consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, and Prostate Diseases.

• Contributors, vii1 Etiology and Pathogenesis, 1Robert H. Getzenberg & Prakash Kulkarni2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates, and Risk Factors, 10Raymond C. Rosen & Benjamin N. Breyer3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction: United States, 22Christopher P. Filson & John T. Wei4 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Europe, 37Stavros Gravas & Jean J. M. C. H. de la Rosette5 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Primary Care, 47Matt T. Rosenberg, John B. Riley & Marty M. Miner6 Watchful Waiting, 59Reginald Bruskewitz7 α-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia, 70Nathaly François, Raunak D. Patel & Kevin T. McVary8 5α-Reductase Inhibitors, 90Claudius Füllhase & Roberto Soler9 Antimuscarinics, 100Nadir I. Osman & Christopher R. Chapple10 The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, 113Casey Lythgoe & Kevin T. McVary11 Combination Medical Therapy for Male Lower Urinary Tract Symptoms, 129Claus G. Roehrborn12 Complementary Therapy, 154Aaron E. Katz & Anne Darves-Bornoz13 Open Simple Prostatectomy, 164Annika Herlemann, Matthias Oelke & Christian Gratzke14 Minimally Invasive Therapies, 175Mauro Gacci, Matteo Salvi and Arcangelo Sebastianelli15 Holmium Laser Prostatectomy, 184Simon van Rij & Peter J. Gilling16 Benign Prostatic Hyperplasia: GreenLight Laser Therapy, 191Alexis E. Te & Bilal Chughtai17 Principles of Electrocautery-Based Techniques, 201Aaron M. Bernie & Richard LeeIndex, 211

Select Guide Rating

Steven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USADr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of Urology, Journal of Urology, Wiley's BJUI and Urology Times. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.Kevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USADr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the Journal of Urology, Journal of the American Medical Association (JAMA), New England Journal of Medicine, International Journal of Impotence Research, and Urology. He is an editorial consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, and Prostate Diseases.

• Contributors, vii1 Etiology and Pathogenesis, 1Robert H. Getzenberg & Prakash Kulkarni2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates, and Risk Factors, 10Raymond C. Rosen & Benjamin N. Breyer3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction: United States, 22Christopher P. Filson & John T. Wei4 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Europe, 37Stavros Gravas & Jean J. M. C. H. de la Rosette5 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Primary Care, 47Matt T. Rosenberg, John B. Riley & Marty M. Miner6 Watchful Waiting, 59Reginald Bruskewitz7 α-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia, 70Nathaly François, Raunak D. Patel & Kevin T. McVary8 5α-Reductase Inhibitors, 90Claudius Füllhase & Roberto Soler9 Antimuscarinics, 100Nadir I. Osman & Christopher R. Chapple10 The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, 113Casey Lythgoe & Kevin T. McVary11 Combination Medical Therapy for Male Lower Urinary Tract Symptoms, 129Claus G. Roehrborn12 Complementary Therapy, 154Aaron E. Katz & Anne Darves-Bornoz13 Open Simple Prostatectomy, 164Annika Herlemann, Matthias Oelke & Christian Gratzke14 Minimally Invasive Therapies, 175Mauro Gacci, Matteo Salvi and Arcangelo Sebastianelli15 Holmium Laser Prostatectomy, 184Simon van Rij & Peter J. Gilling16 Benign Prostatic Hyperplasia: GreenLight Laser Therapy, 191Alexis E. Te & Bilal Chughtai17 Principles of Electrocautery-Based Techniques, 201Aaron M. Bernie & Richard LeeIndex, 211

Select Guide Rating

Steven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USADr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of Urology, Journal of Urology, Wiley's BJUI and Urology Times. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.Kevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USADr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the Journal of Urology, Journal of the American Medical Association (JAMA), New England Journal of Medicine, International Journal of Impotence Research, and Urology. He is an editorial consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, and Prostate Diseases.

• Contributors, vii1 Etiology and Pathogenesis, 1Robert H. Getzenberg & Prakash Kulkarni2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates, and Risk Factors, 10Raymond C. Rosen & Benjamin N. Breyer3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction: United States, 22Christopher P. Filson & John T. Wei4 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Europe, 37Stavros Gravas & Jean J. M. C. H. de la Rosette5 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Primary Care, 47Matt T. Rosenberg, John B. Riley & Marty M. Miner6 Watchful Waiting, 59Reginald Bruskewitz7 α-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia, 70Nathaly François, Raunak D. Patel & Kevin T. McVary8 5α-Reductase Inhibitors, 90Claudius Füllhase & Roberto Soler9 Antimuscarinics, 100Nadir I. Osman & Christopher R. Chapple10 The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, 113Casey Lythgoe & Kevin T. McVary11 Combination Medical Therapy for Male Lower Urinary Tract Symptoms, 129Claus G. Roehrborn12 Complementary Therapy, 154Aaron E. Katz & Anne Darves-Bornoz13 Open Simple Prostatectomy, 164Annika Herlemann, Matthias Oelke & Christian Gratzke14 Minimally Invasive Therapies, 175Mauro Gacci, Matteo Salvi and Arcangelo Sebastianelli15 Holmium Laser Prostatectomy, 184Simon van Rij & Peter J. Gilling16 Benign Prostatic Hyperplasia: GreenLight Laser Therapy, 191Alexis E. Te & Bilal Chughtai17 Principles of Electrocautery-Based Techniques, 201Aaron M. Bernie & Richard LeeIndex, 211

Select Guide Rating